NICE Ltd
NICE
116.42
+1.09
+0.95%
NICE Ltd
US · NICE
#1814 by market cap
Listed 1970
116.42
+1.09
+0.95%
Live - 5344 symbols - heartbeat 73s ago
· 2026-10-08 08:25
Pre-market
115.74
-0.58%
After-hours
116.42
0.00%
- Market cap
- 6.92B
- P/E (TTM)i
- 16.95
- P/Bi
- 1.83
- EPSi
- 9.67
- Div yieldi
- 0.00%
- 52W posi
- 60%
Reader sentiment
Are you bullish or bearish on NICE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.39, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.68% YoY
Margins
- Gross margin
- 66.41%
- Operating margin
- 21.92%
- Net margin
- 20.78%
Key ratios & quality
- PEG ratioi
- 0.53
- Altman Z-Scorei
- 5.39
PEG uses trailing P/E against the 3-year net income growth rate (32.03%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.44B | 1.57B | 1.65B | 1.92B | 2.18B | 2.38B | 2.74B | 2.95B |
| Gross profit | 947.70M | 1.04B | 1.09B | 1.30B | 1.50B | 1.61B | 1.83B | 1.96B |
| Selling & admin expenses | 566.26M | 609.71M | 625.84M | 761.60M | 856.36M | 851.40M | 919.19M | 949.94M |
| Research & development | 183.83M | 193.72M | 218.18M | 271.19M | 306.07M | 322.71M | 360.61M | 360.45M |
| Operating profit | 197.62M | 238.72M | 242.05M | 263.91M | 335.17M | 435.23M | 545.95M | 645.76M |
| Pretax profit | 186.72M | 234.27M | 237.19M | 240.62M | 345.33M | 457.70M | 604.83M | 704.02M |
| Tax | 27.38M | 48.37M | 40.84M | 41.40M | 79.39M | 119.40M | 162.24M | 91.92M |
| Net profit | 159.34M | 185.90M | 196.35M | 199.22M | 265.95M | 338.30M | 442.59M | 612.10M |
| Basic EPS | 3 | 3 | 3 | 3 | 4 | 5 | 7 | 10 |
| Diluted EPS | 2.52 | 2.88 | 2.98 | 2.98 | 4.00 | 5.11 | 6.76 | 9.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 700.19M | 726.71M | 732.00M | 786.50M | 768.62M | 782.29M |
| Gross profit | 468.11M | 485.11M | 489.07M | 513.85M | 494.80M | 501.01M |
| Selling & admin expenses | 230.84M | 234.76M | 237.83M | 246.51M | 270.57M | 294.18M |
| Research & development | 89.10M | 89.76M | 90.46M | 91.12M | 97.48M | 102.83M |
| Operating profit | 148.17M | 160.59M | 160.77M | 176.22M | 126.75M | 104.00M |
| Pretax profit | 164.02M | 175.41M | 181.91M | 182.68M | 146.07M | 107.61M |
| Tax | 34.73M | -11.99M | 37.06M | 32.12M | 99.25M | 24.38M |
| Net profit | 129.29M | 187.40M | 144.85M | 150.55M | 46.81M | 83.23M |
| Basic EPS | 2 | 3 | 2 | 2 | 1 | 1 |
| Diluted EPS | 2.01 | 2.96 | 2.29 | 2.41 | 0.77 | 1.40 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 861.24M | 875.69M | 1.94B | 2.30B | 2.42B | 2.31B | 2.50B | 1.38B |
| Cash & ST investments | 485.83M | 439.10M | 1.46B | 1.42B | 1.57B | 1.41B | 1.62B | 417.40M |
| Inventory | 3.43M | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 3.21B | 3.61B | 4.23B | 4.71B | 4.85B | 5.12B | 5.30B | 5.11B |
| Total current liabilities | 624.91M | 940.96M | 1.04B | 1.27B | 1.14B | 1.12B | 1.47B | 887.63M |
| Short-term debt | -- | 273.10M | 282.29M | 415.46M | 222.82M | 222.98M | 471.35M | 13.74M |
| Long-term debt | 455.99M | 213.31M | 421.34M | 429.27M | 455.38M | 457.08M | -- | -- |
| Total liabilities | 1,190,753,000.00 | 1,352,639,000.00 | 1,644,433,000.00 | 1,872,453,000.00 | 1,798,996,000.00 | 1,763,134,000.00 | 1,692,743,000.00 | 1,229,502,000.00 |
| Total equity | 2.02B | 2.26B | 2.59B | 2.84B | 3.06B | 3.35B | 3.60B | 3.88B |
| Retained earnings | 1.07B | 1.26B | 1.45B | 1.65B | 1.93B | 2.26B | 2.70B | 3.31B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.46B | 2.54B | 1.38B | 1.38B | 1.30B | 1.47B |
| Cash & ST investments | 1.61B | 1.63B | 455.89M | 417.40M | 304.07M | 354.69M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.23B | 5.31B | 5.15B | 5.11B | 4.98B | 5.12B |
| Total current liabilities | 1.54B | 1.38B | 980.24M | 887.63M | 1.06B | 1.10B |
| Short-term debt | 471.41M | 472.16M | 12.78M | 13.74M | 13.59M | 14.03M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,732,032,000.00 | 1,578,444,000.00 | 1,290,776,000.00 | 1,229,502,000.00 | 1,306,265,000.00 | 1,343,433,000.00 |
| Total equity | 3.50B | 3.73B | 3.86B | 3.88B | 3.68B | 3.78B |
| Retained earnings | -- | -- | -- | 3.31B | -- | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 396.61M | 374.16M | 480.31M | 461.82M | 479.72M | 561.43M | 832.64M | 716.55M |
| Depreciation & amortization | 157.14M | 173.23M | 182.03M | 184.09M | 176.55M | 167.36M | 205.02M | 199.04M |
| Free cash flow | 332.94M | 312.19M | 417.02M | 394.61M | 397.83M | 477.25M | 732.87M | 622.80M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -26.00M | -47.28M | -48.27M | -73.18M | -144.94M | -288.44M | -369.20M | -488.91M |
| Ending cash balance | 242.10M | 228.32M | 442.27M | 378.66M | 533.10M | 513.31M | 485.03M | 382.01M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 285.07M | 61.32M | 190.50M | 179.66M | 179.25M | 122.66M |
| Depreciation & amortization | 43.44M | 44.61M | 48.92M | 62.07M | 61.84M | 62.37M |
| Free cash flow | 264.64M | 38.61M | 163.58M | 155.98M | 148.79M | 93.12M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -252.33M | -30.84M | -40.55M | -165.19M | -253.25M | -57.95M |
| Ending cash balance | 471.60M | 536.57M | 420.17M | 382.01M | 263.71M | 319.17M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.46 | 8.70 | 8.16 | 7.39 | 9.07 | 10.60 | 12.77 | 16.40 |
| ROA %i | 5.27 | 5.45 | 5.02 | 4.46 | 5.56 | 6.79 | 8.50 | 11.77 |
| ROIC %i | 7.07 | 6.60 | 6.29 | 5.65 | 6.73 | 7.95 | 9.55 | 13.91 |
| 5-year avg ROE %i | 10.69 | 10.73 | 8.42 | 8.30 | 8.35 | 8.78 | 9.60 | 11.25 |
| EBIT margin %i | 14.18 | 16.08 | 15.45 | 13.35 | 16.00 | 19.41 | 22.12 | 23.90 |
| FCF / sales %i | 23.05 | 19.84 | 25.30 | 20.54 | 18.24 | 20.07 | 26.79 | 21.14 |
| Current ratioi | 1.38 | 0.93 | 1.86 | 1.81 | 2.12 | 2.06 | 1.70 | 1.55 |
| Quick ratioi | 1.24 | 0.81 | 1.70 | 1.44 | 1.83 | 1.78 | 1.54 | 1.31 |
| Debt / assetsi | 14.22 | 16.34 | 18.80 | 19.66 | 16.02 | 15.30 | 10.64 | 1.74 |
| LT debt / equityi | 22.61 | 14.03 | 20.03 | 18.07 | 18.23 | 16.76 | 2.57 | 1.94 |
| Interest coveragei | 11.34 | 13.44 | 14.62 | 16.26 | 93.98 | 124.67 | 3,878.09 | -- |
| Revenue CAGR (3Y) %i | 15.94 | 15.73 | 7.35 | 9.97 | 11.49 | 12.99 | 12.50 | 10.53 |
| Net income CAGR (3Y) %i | -14.93 | 16.72 | 11.07 | 7.73 | 12.68 | 19.88 | 30.48 | 32.03 |
| FCF CAGR (3Y) %i | 12.42 | 17.50 | 8.46 | 5.83 | 8.42 | 4.60 | 22.92 | 16.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 13.40 | 14.95 | 15.11 | 16.40 | 14.76 | 11.33 |
| ROA %i | 9.06 | 10.37 | 10.85 | 11.77 | 10.37 | 8.16 |
| ROIC %i | 10.34 | 12.95 | 12.38 | 13.91 | 12.43 | 10.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 22.75 | 23.37 | 23.71 | 23.90 | 22.65 | 20.40 |
| FCF / sales %i | 27.72 | 23.26 | 24.02 | 21.14 | 16.82 | 18.29 |
| Current ratioi | 1.60 | 1.83 | 1.41 | 1.55 | 1.22 | 1.33 |
| Quick ratioi | 1.46 | 1.67 | 1.19 | 1.31 | 1.01 | 1.08 |
| Debt / assetsi | 10.30 | 10.15 | 1.69 | 1.74 | 1.73 | 1.72 |
| LT debt / equityi | 1.92 | 1.79 | 1.92 | 1.94 | 1.97 | 1.96 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Customer Engagement is the largest reported line at 83.52% of revenue, across 2 reported segments.
- The next-largest line, Financial Crime and Compliance, is a distant second at 16.48% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Customer Engagement83.52%
Financial Crime and Compliance16.48%
Region
Americas, principally the US83.71%
Europe, the Middle East and Africa (EMEA)10.92%
Asia Pacific5.25%
Israel0.12%
Quote time 2026-10-08 08:25:24 · For reference only, not investment advice and not tailored to your situation.